Nath Bio-Genes (India) Ltd share price logo

Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN

BSE: 537291

Small Cap

FMCG Sector

Retail Sector

₹174.30

+2.30

(+1.34%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Nath Bio-Genes Stock Performance

as on April 29, 2026 at 5:13 pm IST

  • Day's Low

    Day's High

    ₹171.62
    ₹176.39
    downward going graph

    1.54%

    Downside

    1.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹126.15
    ₹238.69
    downward going graph

    27.62%

    Downside

    36.94%

    Upside

    downward going graph

Nath Bio-Genes share price movements today

Previous Close
₹172.00
Open
₹174.32
Volume
7,538.00
Upper Circuit
₹206.40
Lower Circuit
₹137.60
Day's Low - High
₹171.62 - ₹176.39
52 Week Low - High
₹126.15 - ₹238.69

Nath Bio-Genes Historical Returns

1 Month Return
+ 33.31 %
3 Month Return
+ 18.88 %
1 Year Return
+ 8.98 %
3 Year Return
+ 5.1 %
5 Year Return
-50.88 %

Nath Bio-Genes Fundamentals

as on April 29, 2026 at 11:43 am IST

Market Cap

₹326.87 Cr

Return on Equity (ROE)

6.69

PE Ratio (TTM)

7.36

Return on capital employed (ROCE)

7.25

Industry PE ratio

58.59

Beta (LTM)

0.9

P/B Ratio

0.43

Dividend Yield

1.37

PEG Ratio

3.42

Quarterly Earnings Growth YOY

-39.62

EPS (TTM)

20.31

Sector

FMCG

Book Value

339.08

Nath Bio-Genes Stock Valuation

as on April 29, 2026 at 11:43 am IST

Nath Bio-Genes in the last 5 years

  • Overview

  • Trends

Lowest (-3.78x)

January 3, 2023

Today (7.36x)

April 28, 2026

Industry (58.59x)

April 28, 2026

Highest (11.85x)

August 4, 2023

LowHigh

Today’s Price to Earnings Ratio: 7.36x

Nath Bio-Genes Technical Analysis

Track how Nath Bio-Genes technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish5
Bullish3
Neutral7

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bullish
CCI (20)
-66.67
Neutral
RSI (14)
41.6
Neutral
Momentum (10)
0
Neutral
ADI (14)
83.36
Neutral
Ultimate Oscillator (7,14,28)
7.21
Bearish

Moving Averages

Name

Value

Action

SMA (20)
174.3
Neutral
EMA (20)
174.3
Bearish
VWMA (20)
174.3
Neutral
SMA (50)
174.3
Bearish
EMA (50)
174.3
Bearish
SMA (200)
173.5
Bullish
EMA (200)
173.67
Bullish
KAMA (200)
174.3
Neutral
DEMA (200)
174.45
Bearish

Nath Bio-Genes (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nath Bio-Genes with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Nath Bio-Genes (India) Ltd image
Nath Bio-Genes (India) Ltd
NA326.87-10.18%0.5838364
Procter & Gamble Hygiene and Health Care Ltd image
Procter & Gamble Hygiene and Health Care Ltd
BUY33,080.74-4.88%0.006363,374
Hatsun Agro Product Ltd image
Hatsun Agro Product Ltd
HOLD21,598.794.23%0.802788,699
Spectrum Foods Ltd image
Spectrum Foods Ltd
NA32.091.89%0.00122
Paos Industries Ltd image
Paos Industries Ltd
NA28.0860%0.00-1NA
See all

Nath Bio-Genes Stock’s Investor Sentiment and Interest

Search interest for Nath Bio-Genes (India) Ltd Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:42% versus previous 30 day period

Nath Bio-Genes (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
235.28
22.57
31.74
43.04
243.88
32.19
36.87
51.97
283.7
43.85
65.96
Other Income
0.12
0.06
2.54
1.36
0.13
0.08
0.48
4.4
3.83
4
4.42
Total Income
235.4
22.63
34.27
44.4
244.01
32.27
37.35
56.37
287.53
47.85
70.38
Expenses
198.25
17.59
26.09
39.11
207.34
27.38
28.84
51.55
245.42
37.75
62.39
Operating Profit
37.03
4.98
5.65
3.93
36.54
4.81
8.03
0.42
38.28
6.1
3.57
Operating Profit Margin %
15.74%
22.06%
17.8%
9.13%
14.98%
14.94%
21.78%
0.81%
13.49%
13.91%
5.41%
Profit Before Interest, Tax and Depreciation
37.15
5.04
8.18
5.29
36.67
4.89
8.51
4.82
42.11
10.1
8
Interest
2.76
2.44
2.84
1.07
2.24
2.98
3.9
1.37
3.2
3.66
4.54
Depreciation
0.76
0.76
0.76
0.98
0.83
0.83
0.83
1.34
0.98
0.99
0.98
Profit Before Tax
33.63
1.84
4.58
3.24
33.6
1.08
3.78
2.11
37.93
5.45
2.48
Tax Paid
0.22
0.35
0.77
0.62
0.25
-0.03
1.14
0.63
0.66
0.64
0.87
Profit After Tax
33.4
1.5
3.82
2.62
33.35
1.11
2.65
1.48
37.28
4.82
1.6
Total Net profit including share of profit / Loss from associate company
33.4
1.5
3.82
2.62
33.35
1.11
2.65
1.48
37.28
4.82
1.6
EPS
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
2.53
0.84
Actual EPS
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
2.53
0.84
Adjusted EPS
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
2.53
0.84
Diluted EPS
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
2.53
0.84

Nath Bio-Genes (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
278.36
301.36
332.62
364.91
Other Income
1.85
0.55
4.08
5.09
Total Income
280.22
301.92
336.7
369.99
Expenses
329.96
252.62
282.76
315.11
Operating Profit
-51.6
48.74
49.86
49.8
Operating Profit Margin %
-18.54%
16.17%
14.99%
13.65%
Profit Before Interest, Tax and Depreciation
-49.74
49.3
53.94
54.88
Interest
10.61
10.12
9.11
10.48
Depreciation
3.08
3.01
3.26
3.82
Profit Before Tax
-63.43
36.17
41.57
40.58
Tax Paid
3.95
1.15
1.95
1.98
Profit After Tax
-67.39
35.01
39.62
38.6
Total Net profit including share of profit / Loss from associate company
-67.39
35.01
39.62
38.6
EPS
-35.46
18.44
21.34
20.14
Actual EPS
-35.46
18.44
21.34
20.14
Adjusted EPS
-35.46
18.44
21.34
20.14
Diluted EPS
-35.46
18.44
21.34
20.14

Nath Bio-Genes (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.05
38.37
74.59
17.58
Cash Flow from Investing Activities
-19.86
-2.88
-27.41
-3.96
Cash Flow from Financing Activities
-22.23
-1.66
-7.78
-2.12
Net Cash Flow
-25.04
33.81
39.41
11.49

Nath Bio-Genes Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
DII
4.62%
4.37%
4.37%
4.37%
4.38%
4.37%
4.37%
3.94%
2.25%
0.76%
0.01%
0.01%
FII
0%
0.22%
0%
0.27%
0.22%
0.19%
0.19%
0.21%
0.42%
0.32%
0.31%
0.23%
Public
49.71%
49.81%
49.72%
49.76%
49.81%
49.85%
49.84%
50.25%
51.74%
53.32%
54.08%
54.17%
Total Outstanding Shares
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
Total Shareholders
33,502
34,365
34,263
35,132
35,834
35,423
35,056
34,911
34,207
34,122
33,550
33,031

Nath Bio-Genes Corporate Actions

View detailed summary of the earnings and dividend history of Nath Bio-Genes.

  • Nath Bio-Genes (India) Ltd Earnings Results

    Nath Bio-Genes (India) Ltd’s net profit fell -39.62% since last year same period to ₹1.60Cr in the Q3 2025-2026. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated -66.8% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Nath Bio-Genes (India) Ltd Dividends April,2025

    In the quarter ending March 2025, Nath Bio-Genes (India) Ltd has declared dividend of ₹2.00 per share on 29 Apr 2025 - translating a dividend yield of 2.30%.

    Read More about Dividends

Insights on Nath Bio-Genes (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NATHBIOGEN stock has moved up by 18.9%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 53.32% to 54.08% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 47.85 Cr → 70.38 Cr (in ₹), with an average increase of 32.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Avanti Feeds Ltd has given 58.9% return, outperforming this stock by 49.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 45.60% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Avanti Feeds Ltd has given 289.4% return, outperforming this stock by 284.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 37.28 Cr → 1.6 Cr (in ₹), with an average decrease of 76.9% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.32% to 0.31% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 0.76% to 0.01% in Dec 2025 quarter

About Nath Bio-Genes (India) Ltd

Nath BioGenes India Limited was established in 1993, as a private limited company, to produce, process and market hybrid and GM seeds. With 16 business centers spanning 131 territories across India, it has an extensive network of 2000 distributors, enabling it to cater to PAN India and far abroad markets in Asia, Africa and the Middle East. To improve the quality of its production, the company has incorporated modern infrastructure facilities, biotech and seed technology labs. Their range of field crop, vegetable crop and plant nutrient supplements have enabled it to gain various prestigious awards, such as the Vasantrao Naik Prathisthan Award, for its contribution towards enhancing agricultural productivity. It has also collaborated with major International and National Centres of Excellence, such as the NRCPB, CIMMYT, IRRI, and ICRISAT. The company has set rigorous field standards, quality control checks, and elaborate seed processing facilities, to ensure that only seeds of the highest quality reaches customers. Its 3-phase trial system with 40 testing locations, 8 centres, and all agroclimatic zones of India, has enabled it to rigorously test products and compare yields with competitor products. This comprehensive system has allowed Nath BioGenes India Limited to be a successful hybrid and GM seed provider in India and internationally.

Revenue: ₹65.96Cr as on December 2025 (Q3 FY26)
Net Profit: ₹1.60Cr as on December 2025 (Q3 FY26)
Listing date: 28 Jan, 2014
OrganisationNath Bio-Genes (India) Ltd
IndustryFMCG
E-voting on sharesClick here to vote

FAQs

What is Nath Bio-Genes share price today?

Nath Bio-Genes share price today stands at ₹174.3 as on . Nath Bio-Genes share today touched a day high of ₹176.39 and a low of ₹171.62.

What is the 52 week high and 52 week low range for Nath Bio-Genes share?

Nath Bio-Genes touched a 52 week high of ₹238.69 and a 52 week low of ₹126.15. Nath Bio-Genes share price today i.e. is trending at ₹174.3, which is -26.98% down from its 52 week high and 38.17% up from its 52 week low.

What is Nath Bio-Genes's market capitalisation today?

Nath Bio-Genes market capitalisation is ₹326.87 Cr as on .

How to buy Nath Bio-Genes shares?

To buy Nath Bio-Genes shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NATHBIOGEN or Nath Bio-Genes (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Nath Bio-Genes shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Nath Bio-Genes trading volume today?

Nath Bio-Genes trading volume is 7,538.00 as on . This means that 7,538.00 shares of Nath Bio-Genes were bought and sold on the stock market during today's trading session.